Navigation Links
Small Business Innovation Research Program Awards Grant to Biomoda
Date:6/25/2008

conduct a $350,000 clinical study using Biomoda's proprietary testing technology for detection of early lung cancer in the state's veterans. The New Mexico state legislature recently allocated an additional $1.3 million in funding.

Lung cancer claims more lives than any other cancer. The expected five- year survival rate for all patients diagnosed with lung cancer is 15 percent; the five-year survival rate for cases detected when the disease is still localized is 50 percent. Presently, only 16 percent of lung cancer cases are diagnosed at this early stage.

Biomoda's technology was originally developed at Los Alamos National Laboratory.

Contact: John Cousins

505-821-0875

investor@biomoda.com

Forward-Looking Statements

All statements in this press release that are not historical are forward- looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of BIOMODA's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. BIOMODA, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in BIOMODA's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.


'/>"/>
SOURCE Biomoda, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
2. New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
3. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
4. Albemarle Optimizes Smallpox Drug Candidate for SIGA
5. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
6. Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
7. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
8. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
9. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
10. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
11. Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2008)...RT WORTH, Texas, Aug. 26 /- Healthpoi...l trial to evaluate the effectiveness of a,widely ...taneous wounds and,resulting scars. The pilot stud...e reduced incidence of hypertrophic scars and bene...ase SANTYL(R) Ointment.(1,2), "Given the findings...
(Date:8/25/2008)... Discovers Stem Cells Found in Menstrual Blood May...cts for Time-Pressed Women, OLDSMAR, Fla., Aug. 2.... Yet most women would agree that there never seem... a woman spends on doing something just,for hersel...sts in others.,This reality has led many women in ...
(Date:8/25/2008)...t Line CLL, NHL and CLL Retreatment and Japanese D...Planned, COPENHAGEN, Denmark, August 25 /PRNewswi...in four studies of ofatumumab in chronic lymphocyt.../S (OMX: GEN) announced today plans to begin four ...mia (CLL) and follicular,non-Hodgkin,s lymphoma (N...
(Date:8/21/2008)...NHATTAN, Kan., Aug. 21 /PRNewswire-USNewswire/ -- ...E. coli O157:H7 expert T.G. Nagaraja has,been tapp...both the,connection between feeding distillers, gr...ategies to reduce the presence of the naturally oc...eceived a $939,220 National Research Initiative in...
Breaking Medicine Technology:Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers' Grains 2Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 1Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 2Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 3UK junior doctors gaining less experience of common procedures 115 1UK junior doctors gaining less experience of common procedures 115 2Ancient organisms discovered in Canadian gold mine 110 1Ancient organisms discovered in Canadian gold mine 110 2Survey reveals disparities in skin cancer knowledge protection among high school students 110 1Survey reveals disparities in skin cancer knowledge protection among high school students 110 2Survey reveals disparities in skin cancer knowledge protection among high school students 110 3
...a,clinical stage nanomedicine company focused on t...ional, tumor-targeted therapies has,been selected ...Society of Clinical Oncology Annual Meeting in Chi...ake place from 8:00 am to 12,noon on June 3. Dr. L...e poster abstract entitled "Preliminary Results of...
...from a large,randomized clinical trial for patien... typically found in bone marrow, has,shown that th...Decadron ®), in combination with lenalidomide ...val when compared to a treatment,regimen with lena...one. The clinical trial was sponsored by the Natio...
Other Medicine Technology:CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2Low-Dose Steroid Combined With Lenalidomide Prolongs Survival,Compared With High-Dose Steroid for Multiple Myeloma Treatment 2Low-Dose Steroid Combined With Lenalidomide Prolongs Survival,Compared With High-Dose Steroid for Multiple Myeloma Treatment 3
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...awa region when the classy gleaming state-of-the-a.../ psychiatric care and research facility was open...uts 188 inpatient beds to public last week. This ...l to be entirely financed and maintained by the pr...
...w symptoms of depression, irascibility, aching joi...st// in sex because of the lack of testosterone, a...found that 52 percent of men between 30 and 40 yea...percent of them say their physical strength and re...
...erapy is becoming the most sought-after treatment ...uty are parlours// and clinics that are offering t...ark circles, flower therapy seems to be the perfec...ers every day," says Neerja, who owns a skin and b...
...for people with Type 2 Diabetes, named ‘Diabetes C...Life Insurance//. Speaking at the inauguration of...urance and Dr.Mohan’s Diabetes Specialties Centre,...ctor, ICICI Prudential Life Insurance, said, "With...
Other Medicine News:
4 mm wide tip.
Double-ended. 3 mm x 5 mm curette end and 3 mm spatula end.
2.5 mm x 4 mm opening. Hexagonal handle.
Double-ended. Sharp and blunt 6.5 mm tips. Designated most popular model or size.
Medicine Products: